A- A A+

A Mobile Buprenorphine Treatment Program for Homeless Patients With Opioid Use Disorder.

Buzza C, Elser A, Seal J.

Psychiatr Serv. 2019 Jul 1;70(7):635-636. doi: 10.1176/appi.ps.70701.


USA. Opioids study shows high-risk counties across the country, suggests local solutions

In a study of more than 3,000 counties across the U.S., the researchers found that residents of 412 counties are at least twice as likely to be at high risk for opioid overdose deaths and to lack providers who can deliver medications to treat opioid use disorder. (MedicalXpress, USA, 28.06.2019)


Factors Associated with Compliance among Methadone Maintenance Treatment Transfers: Evidence from Audit Records at Clinics in Guangdong, China.

Gong C, Zou X, Chen W, Liu Y, Lu Q, Ling L.

Int J Environ Res Public Health. 2019 Jun 6;16(11). pii: E2023. doi: 10.3390/ijerph16112023.


USA. One Possible Solution to the Opioid Crisis in the U.S. Has Been Inexplicably Ignored

The President’s Council of Economic Advisors (CEA) just released a new report on how to beat back America’s opioid crisis. The CEA highlighted as potential solutions measures like curbing illicit drug trafficking, reducing over-prescribing in doctors’ offices, and cracking down on drug distributors fueling the epidemic for profit.

Those are noble goals, to be sure. But the CEA report lacks one crucial element in fighting this crisis: nurse practitioners. (Time, USA, 24.06.2019)


Expanding low-threshold buprenorphineto justice-involved individuals through mobile treatment: Addressing a critical care gap.

Krawczyk N, Buresh M, Gordon MS, Blue TR, Fingerhood MI, Agus D.

J Subst Abuse Treat. 2019 Aug;103:1-8. doi: 10.1016/j.jsat.2019.05.002. 



A scalable, automated warm handoff from the emergency department to community sites offering continued medication for opioid use disorder: Lessons learned from the EMBED trial stakeholders.

Ahmed OM, Mao JA, Holt SR, Hawk K, D'Onofrio G, Martel S, Melnick ER.

J Subst Abuse Treat. 2019 Jul;102:47-52. doi: 10.1016/j.jsat.2019.05.006.


User-centred clinical decision support to implement emergency department-initiated buprenorphine for opioid use disorder: protocol for the pragmatic group randomised EMBED trial.

Melnick ER, Jeffery MM, Dziura JD, Mao JA, Hess EP, Platts-Mills TF, Solad Y, Paek H, Martel S, Patel MD, Bankowski L, Lu C, Brandt C, D'Onofrio G.

BMJ Open. 2019 May 30;9(5):e028488. doi: 10.1136/bmjopen-2018-028488.


Age related medication for addiction treatment (MAT) use for opioid use disorder among Medicaid-insured patients in New York.

Neighbors CJ, Choi S, Healy S, Yerneni R, Sun T, Shapoval L.

Subst Abuse Treat Prev Policy. 2019 Jun 25;14(1):28. doi: 10.1186/s13011-019-0215-4.


Neuseeland. Drug History: What happened when Dunedin cancelled methadone

This article is about what can happen if a drug substitution programme is suddenly cancelled. (publicaddress.net, Neuseeland, 23.06.2019)


Kanada. Free heroin? Unusual clinic offers 'chance at being human again' 

Low-dose drug program provides an alternative to potentially deadly street narcotics. (CBC, Kanada, 09.06.2019)


USA. What Can We Learn From the Nation’s First 24/7 Methadone Clinic?

In October 2017, Community Medical Services (CMS), an Arizona-based addiction treatment provider, opened America’s first medication-assisted treatment (MAT) clinic that operates 24 hours a day, seven days a week. It’s a level of accessibility that will sound almost unimaginably helpful to anyone used to organizing their life around restricted clinic hours.

The first-of-its-kind program, which offers methadone, buprenorphine and naltrexone among other services, is located in North Phoenix near I-17—an area where drug fatality rates are among the highest in the state. (Filter, USA, 20.06.2019)


Portugal. The mobile methadone van that helps drug addicts live normal life

Daily Record chief reporter Mark McGivern visited Lisbon to see if Portugal's enlightened approach to addiction could help tackle Scotland's drug crisis. (Daily Record, Schottland, 19.06.2019)


ACMD report- Ageing cohort of drug users

In recent years, statistics have been published to show a demonstrable shift in age profile of individuals accessing treatment for drug use in the UK. In response to this the Advisory Council on the Misuse of Drugs (ACMD) undertook this self-commissioned report to review the evidence of this trend and assess the implications of an ageing cohort on specialist drug treatment services. In this report,the ACMD describes the changing age profile; provides an overview of the challenges faced by this ageing cohort in the UK; explains why current service regimen  are not meeting the needs of this group and makes recommendations for practise and policy. (ACMD - Advisory Council on the Misuse of Drugs, UK, 14.06.2019)


Number of older opiate users in treatment has tripled

The number of older opiate users in treatment in England has tripled in just 12 years, a report by the ACMD reveals today. (ACMD - Advisory Council on the Misuse of Drugs, UK, 14.06.2019)


Schottland. Methadone overdose figures slammed by Scottish Conservatives

The Conservatives have called for alternative treatments for drug addicts as figures indicate hundreds of people were taken to hospital after overdosing on the heroin replacement methadone.

A total of 222 people were admitted to hospital in 2017-18 due to methadone overdoses. (ITV, UK, 14.06.2019)


Self-Rated Physical Health and Unmet Healthcare Needs among Swedish Patients in Opioid Substitution Treatment.

Troberg K, Håkansson A, Dahlman D.

J Addict. 2019 Apr 15;2019:7942145. doi: 10.1155/2019/7942145. 


USA. Significant barriers to care for patients seeking medication for opioid use

Boston, MA – Buprenorphine-naloxone (buprenorphine), a highly effective, evidence-based treatment for opioid use disorder (OUD), is difficult to access in states with high rates of death associated with OUD, according to new research led by Harvard T.H. Chan School of Public Health. The study also found that access to buprenorphine is especially challenging among patients with Medicaid coverage. (Harvard Chan School of Public Health, USA, 03.06.2019)


Mixed methods to explore factors associated with the decline of patients in the methadone maintenance treatment program in Shanghai, China

Lei Zhang†, Jiayi Bao†,Amy Harrington,Xiaoduo Fan,Zhen Ning,Jingying Zhang,Daqing Shi,Manji Hu,Zhirong Zhou,Zhengyi Cai,Min Zhaoand Jiang Du

†Contributed equally

Harm Reduction Journal 2019, 16:34, doi.org/10.1186/s12954-019-0304-8





Tschechien. Petr’s Journey – Possibilies of Opioid Substitution (Video)

A new movie produced by the alumni of our video training, tells the story of Petr, a 50 years old man from Prague, who lost his leg, his has no home, no job – but his has now hope to change his life with the help of opiate substitution treatment. (Drug Reporter, Ungarn, Video, 09:0414.05.2019)


Buprenorphine in the emergency department: Randomized clinical controlled trial of clonidine versus buprenorphine for the treatment of opioid withdrawal.

Srivastava A, Kahan M, Njoroge I, Sommer LZ.

Can Fam Physician. 2019 May;65(5):e214-e220. PMID: 31088887


ACMT Position Statement: Buprenorphine Administration in the Emergency Department.

Wax PM, Stolbach AI, Schwarz ES, Warrick BJ, Wiegand TJ, Nelson LS.

J Med Toxicol. 2019 May 13. doi: 10.1007/s13181-019-00712-3. 


Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH).

D'Onofrio G, Edelman EJ, Hawk KF, Pantalon MV, Chawarski MC, Owens PH, Martel SH, VanVeldhuisen P, Oden N, Murphy SM, Huntley K, O'Connor PG, Fiellin DA.

Implement Sci. 2019 May 7;14(1):48. doi: 10.1186/s13012-019-0891-5.


Low barrier buprenorphine treatment for persons experiencing homelessness and injecting heroin in San Francisco.

Carter J, Zevin B, Lum PJ.

Addict Sci Clin Pract. 2019 May 6;14(1):20. doi: 10.1186/s13722-019-0149-1.


Opioid use disorder in primary care: PEER umbrella systematic review of systematic reviews.

Korownyk C, Perry D, Ton J, Kolber MR, Garrison S, Thomas B, Allan GM, Dugré N, Finley CR, Ting R, Yang PR, Vandermeer B, Lindblad AJ.

Can Fam Physician. 2019 May;65(5):e194-e206. PMID: 31088885


Quality of primary care among individuals receiving treatment for opioid use disorder.

Spithoff S, Kiran T, Khuu W, Kahan M, Guan Q, Tadrous M, Leece P, Martins D, Gomes T.

Can Fam Physician. 2019 May;65(5):343-351. PMID: 31088874


Telemedicine's Role in Addressing the Opioid Epidemic.

Yang YT, Weintraub E, Haffajee RL.

Mayo Clin Proc. 2018 Sep;93(9):1177-1180. doi: 10.1016/j.mayocp.2018.07.001. 


Facing the Growing Heroin Problem in Colombia: The New Methadone-assisted Treatment Programs.

González G, Giraldo LF, DiGirolamo G, Rey CF, Correa LE, Cano AM, Romero-González M.

Rev Colomb Psiquiatr. 2019 Apr - Jun;48(2):96-104. doi: 10.1016/j.rcp.2017.07.004. Epub 2017 Sep 1. English, Spanish. 



Buprenorphine unobserved "home" induction: a survey of Ontario's addiction physicians.

Srivastava A, Kahan M, Leece P, McAndrew A.

Addict Sci Clin Pract. 2019 May 1;14(1):18. doi: 10.1186/s13722-019-0146-4.


End of Life Care for People with Alcohol and other Drug Problems

This website offers resources developed from a two year research programme on end of life care for people with alcohol and other drug problems. (endoflifecaresubstanceuse.com, UK, Mai 2019)